Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer

Vitor H. Almeida(Universidade Federal do Rio de Janeiro), Robson Q. Monteiro(Universidade Federal do Rio de Janeiro)
Oncotarget
July 17, 2018
Cited by 45


Related Papers